Current activities at the Centers for Disease Control and Prevention's National Diabetes Laboratory.

Diabetes technology & therapeutics

Volumn 1, Issue 4, 1999, Pages 403-409

  Sampson, E J ^a   Barr, J R ^a   Cordovado, S K ^a   Hannon, W H ^a   Henderson, L O ^a   Johnson, A B ^a   Miller, D ^a   Mueller, P W ^a   Myers, G L ^a   Pirkle, J L ^a   Schleicher, R L ^a   Steinberg, K ^a   Sussman, D ^a   Vogt, R F ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLYCOSYLATED HEMOGLOBIN;

ARTICLE; BLOOD; BLOOD GLUCOSE MONITORING; EPIDEMIOLOGY; GENETICS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; METHODOLOGY; MONITORING; PUBLIC HEALTH SERVICE; QUALITY CONTROL; RISK FACTOR; STANDARD; UNITED STATES;

AUTOANTIBODIES; BLOOD GLUCOSE SELF-MONITORING; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); DIABETES MELLITUS, TYPE 1; EPIDEMIOLOGIC METHODS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MONITORING, PHYSIOLOGIC; QUALITY CONTROL; RISK FACTORS; UNITED STATES;

EID: 0033301572     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/152091599316919     Document Type: Article

References (0)